Quick Links

 Selected Publications

Ito JI, Lyons JM, Hong TB, Tamae D, Liu Y-K, Wilczynski SP, Kalkum M. 2006. Vaccinations with recombinant variants of Aspergillus fumigatus Asp f3 protect against invasive aspergillosis. Infect. Immun. 74:5075-5084.

Ito JI, Tegtmeier BR, O’Donnell MR. 2006. Antibacterial prophylaxis in patients with cancer and neutropenia. N Engl J Med 354:91-92.

Balajee SA, Gribskov J, Brandt M, Ito JI, Fothergill A, Marr KA. 2005. Mistaken identity: Neosartorya pseudofischeri pseudofischeri and its anamorph masquerading as A. fumigatus. J Clin Microbiol 43:5996-5999.

Lyons JM, Morre SA, Airo-Brown LP, Pena AS, Ito JI. 2005. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection. BMC-Infectious Diseases 5:105.

Lyons JM, Moore SA, Airo-Brown LP, Pena AS, Ito JI. 2005. Comparison of multiple genital tract infections with Chlamydia trachomatis genital tract infection in different strains of female mice. J Microbiol Immunol Infect 38:383 -393.

Ito JI, Chandrasekar PH, Hooshmand-Rad R. 2005. Efficacy of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA). Bone Marrow Transplant 36(10):873-677.

Chandrasekar PH, Ito JI. 2005. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients. Clin Infect Dis 40 (suppl 6):S392-400.

Ito JI, Hooshmand-Rad R. 2005. Treatment of Candida Infections with Amphotericin B lipid complex. Clin Infect Dis 40 (suppl 6):S384-391.

Lyons JM, Ito JI, Pena AS, Morre SA. 2005. Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chalmydia muridarum. J Clin Pathol 58:397-401.

Lyons, JM, Ito, JI, Morre SA. 2004. Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: Host factors as major determinants of C trachomatis mediated pathogenesis. J Clin Pathol 57(6):657-659.

Ito, JI. 2004. Herpes Simplex virus Infections. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas Hematopoietic Cell transplantation. Malden, MA: Blackwell Publishing, 2004: 727-731.

Ito JI. 2004. Infectious Complications. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD, eds. Cancer Management: A Multidisciplinary Approach. 8th ed., Manhasset, NY: CMP Healthcare Media. 983-1012. (Also: editions 1-7; 1996-2003)

Ito JI and Lyons JM. 2002. Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis. J Infect Dis 2002;186-869-71.

Moore, SA, Lyons, JM, Ito, JI, Jr. 2000. Murine Models of Chlamydia trachomatis Genital Tract Infection. Use of Mouse Pneumonitis Strain versus Human Strains. Infect. Immun. 68:7209-7211.

Ito JI and Lyons JM. 1999. Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect. Immun. 67:5518-5521.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last reviewed: 07/08.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.